Read + Share
Tendler S, De Gregorio R, Balderes P, Michel AL, et al. Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade
neuroendocrine lung and prostate cancers. Proc Natl Acad Sci U S A 2026;123:e2505785123.
PMID: 41628333
|
 |
|
Tendler S, De Gregorio R, Balderes P, Michel AL, et al. Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade
neuroendocrine lung and prostate cancers. Proc Natl Acad Sci U S A 2026;123:e2505785123.
PMID: 41628333
|
|
|
|